Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.

about

Advances and Challenges of Liposome Assisted Drug Delivery It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug A complex game of hide and seek: the search for new antifungals

P2860

Q26773160-D0C7C885-8483-480F-852B-229D7F1A070F Q34302880-3B74AFCB-4F95-4185-A2BC-4A8FC26CDEF0 Q37344546-3E3CF3F6-0087-4A6D-8A97-BC672A81C950

P2860

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.

Item

http://www.wikidata.org/entity/Q41897364

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Amphotericin B lipid complex: ...... f amphotericin B deoxycholate.

@en

type

Item

label

Amphotericin B lipid complex: ...... f amphotericin B deoxycholate.

@en

prefLabel

Amphotericin B lipid complex: ...... f amphotericin B deoxycholate.

@en

P1476

Amphotericin B lipid complex: ...... f amphotericin B deoxycholate.

@en

P2093

Ph Chandrasekar

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

The epidemiology of sepsis in the United States from 1979 through 2000

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

Candida lusitaniae infections in the era of fluconazole availability.

A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations.

P304

1285-1294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S1554

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19337435

http://www.w3.org/2001/XMLSchema#string

P932

2643109

http://www.w3.org/2001/XMLSchema#string

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.

about

P2860

P2860

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932